載入...
Clinicopathologic characteristics and outcomes of Chinese patients with non‐small‐cell lung cancer and BRAF mutation
BRAF mutation is one of the important driver oncogene in non‐small‐cell lung cancer (NSCLC). Data on Chinese patients with BRAF‐mutant NSCLC are inadequate. Hence, we conducted this study to investigate the clinicopathologic features and outcomes of Chinese patients with NSCLC and BRAF mutations. We...
Na minha lista:
| 發表在: | Cancer Med |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5345676/ https://ncbi.nlm.nih.gov/pubmed/28135039 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1014 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|